RecruitingNot Applicable

A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines

Austria70 participantsStarted 2026-01-16

Plain-language summary

This study will serve to collect and analyze additional data on the use of the device croma revitalis for treatment of fine lines on the face including LCL and PR in the routine practice and as "real-world" performance.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

. Energy based device treatments that target collagen remodeling and/or production of collagen (e.g. laser therapy).
. Absorbable sutures (threads).
. HA or collagen dermal fillers.
. Botulinum toxin treatment.
. Facial lipolysis, including submental fat treatments.
. Facial plastic surgery.
. Bariatric surgery.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Responder status at Week 8 after initial treatment.

Timeframe: 8 weeks after initial treatment

Trial details

NCT IDNCT07492277

SponsorCroma-Pharma GmbH

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-07-15

Contact for this trial

Head of Clinical Operations

+43226268468 clinical.studies@croma.at

View on ClinicalTrials.gov More Lateral Canthal Lines (LCL) trials